November 2010 - Page 22 of 26

ThursdayNov 04, 2010 10:13 am

Uranium Energy Corp. (UEC) Jumps As Uranium Prices Come Back

The price of uranium, like that of all commodities, is based on a volatile mix of many variables feeding supply and demand. Like rogue waves on a choppy sea, spikes and troughs can easily mislead, disguising powerful general trends. When the spot price of uranium peaked in 2007, only to fall back over the following few years, there was no shortage of pundits attempting to target the bottom, which now appears to have been hit and solidly defined. The spot price of uranium has now increased 25% since earlier this year, and exploration/development companies like Uranium Energy Corp. have shot…

ThursdayNov 04, 2010 8:14 am

LianDi Clean Technology Inc. (LNDT.OB) Announces Major Contract with Sinopec Mitsubishi Chemical

Located in Beijing, China, LianDi serves the largest Chinese petroleum and petrochemical companies by providing clean technology, downstream flow equipment and engineering services. While only established in 2004, LianDi is quickly becoming a major player in the rapidly growing clean technology market for oil refineries in China. Today, LianDi announced four contracts from Sinopec Mitsubishi Chemical with a combined worth of $3 million. With these contracts, the young company will supply 222 valves to Sinopec Mitsubishi, a subsidiary of Sinopec. LianDi expects delivery to Sinopec Mitsubishi Chemical in the first half of 2011. LianDi Clean Technology will supply all the…

ThursdayNov 04, 2010 8:10 am

Echo Therapeutics Inc. (ECTE.OB) Receives Qualifying Therapeutic Discovery Project Grant for 2009 Research and Development Endeavors

Echo Therapeutics, Inc. announced this morning that it received a Qualifying Therapeutic Discovery Project (QTDP) grant from the U.S. government in the amount of $244,479 related to its 2009 research and development expenditures. Based on its actual and projected R&D spending for 2010, Echo expects to receive an additional grant of up to approximately $244,000 after submission of its 2010 tax returns. The U.S. Department of Health and Human Services issues QTDP grants to support innovative projects that have reasonable potential to result in new therapies, reduce health care costs or significantly advance the goal of curing cancer. Created under…

ThursdayNov 04, 2010 8:07 am

Dionics, Inc. (DION.OB) Announces Progress in Initiative Aimed at Expanding Asian Market

Yesterday, Dionics, Inc. announced the progress they have made in regards to generating growth in the expanding Chinese market. Dionics, a manufacturer of semiconductors and microelectronics, is known particularly for its photovoltaic MOSFET drivers. Among the steps taken are the hiring of a respected local Chinese consulting firm, and having an operating sales and marketing function in Bejing through this consulting firm. In addition, these consultants are in the process of screening candidates for Merger/Acquisition routes. Further action is being taken in ongoing negotiations with a large number of Chinese electronics companies to distribute their MOSFET drivers in the Chinese…

ThursdayNov 04, 2010 8:04 am

InSite Vision Inc. (INSV.OB) Awarded Therapeutic Discovery Project Grant

InSite Vision Inc. announced yesterday that they will receive $489,000 under the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) program. The grant was awarded in recognition of two clinical-stage programs. One is ISV-502, a product candidate being developed for the treatment of blepharitis. The other is ISV-303; a topical anti-inflammatory product intended to reduce the pain and inflammation associated with ocular surgery. The QTDP credit is available to biotechnology companies who are conducting studies or carrying out research for the purpose of securing approval from the U.S. Food and Drug Administration for products that address an area of unmet medical…

ThursdayNov 04, 2010 8:02 am

Access Pharmaceuticals, Inc. (ACCP.OB) Commences Phase II Trial for Ovarian Drug

Access Pharmaceuticals Inc. is a biopharmaceutical company that develops and commercializes proprietary products for the treatment and supportive care of cancer patients. The company recently commenced a phase II combination trial for its second generation DACH-platinum ovarian cancer drug ProLindac. The trial is a study of intravenously administered ProLindac, in combination with paclitaxel; the trial will be conducted in up to eight European centers. Proessor Esteban Cvitkovic, vice chairman, Europe, and senior director of Clinical Oncology R&D for Access, said the phase II trial is one of many studies to observe potential applications for ProLindac in the healthcare market. "We…

ThursdayNov 04, 2010 7:58 am

eDoorways International Corp. (EDWY.PK) Engages Investor Relations Firm for Additional Support

Today before the opening bell, eDoorways International Corp. announced that they have retained ATG Capital to provide additional Investor Relations support. “We have arrived at an exciting time in our company where we have advanced to the next level with our capabilities and services,” stated Gary Kimmons, CEO of eDoorways International Corporation. “ATG Capital will be working hand in hand with Heritage Corporate Services to ensure our technology is introduced and utilized by the global community,” Kimmons continued. “After we were introduced to this incredible technology, we instantly knew we wanted to work with eDoorways and assist in their continued…

WednesdayNov 03, 2010 3:16 pm

IDO Security, Inc. (IDOI.OB) Announces Participation at the Israel Homeland Security International Conference

IDO Security, Inc., developer of the innovative Magshoe™ shoe scanning device, announced earlier today that it exhibited its new MagShoe™ 3G at the Israel Homeland Security International Conference which was held October 31 to November 3, 2010 in Tel Aviv, Israel. Delegates and security officials from countries worldwide attended the conference to discuss homeland security topics such as technology advances, airport security, crisis management and safe communities. "This was a significant conference for us to showcase the MagShoe™ 3G. Officials from around the world gathered here to discuss the increased threats our nations are faced with today," commented Dani Werber,…

WednesdayNov 03, 2010 2:45 pm

PDC Energy (PDC) Purchases Oil and Gas Assets in Texas

PDC Energy reported that the company has entered into a purchase agreement to buy producing oil and gas properties in the Permian Basin. The company said that the deal is with an unidentified private oil and gas company. PDC Energy will pay $40 million for 5,760 net acres that has exposure to the Wolfberry oil trend in West Texas. The properties have current production of 330 barrels of oil equivalent (BOE) per day from six existing wells. PDC Energy reported that the acreage block has approximately 122 future drilling locations into the Wolfberry formation assuming 40 acre spacing. The Wolfberry…

WednesdayNov 03, 2010 2:43 pm

Gasco Energy, Inc. (GSX) Reports Increase in Revenue for the Third Quarter of 2010

Gasco Energy, Inc. reported an increase in revenues during the third quarter of 2010 as the company benefited both from higher volumes and higher realized prices for oil and gas sales. Gasco Energy, Inc. said that the company had sales of $4.7 million in the third quarter of 2010, compared to $3.6 million in the same quarter of 2009. Gasco Energy, Inc. realized a natural gas price of $4.35 per thousand cubic feet during the quarter. The company received $4.06 per thousand cubic feet for its natural gas in the third quarter of 2009. Much of the increase in realized…

Site Search

Company Search

Month: November 2010